206 related articles for article (PubMed ID: 22694755)
1. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.
Sarwal MM; Ettenger RB; Dharnidharka V; Benfield M; Mathias R; Portale A; McDonald R; Harmon W; Kershaw D; Vehaskari VM; Kamil E; Baluarte HJ; Warady B; Tang L; Liu J; Li L; Naesens M; Sigdel T; Waskerwitz J; Salvatierra O
Am J Transplant; 2012 Oct; 12(10):2719-29. PubMed ID: 22694755
[TBL] [Abstract][Full Text] [Related]
2. Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation.
Naesens M; Salvatierra O; Benfield M; Ettenger RB; Dharnidharka V; Harmon W; Mathias R; Sarwal MM;
Am J Transplant; 2012 Oct; 12(10):2730-43. PubMed ID: 22694733
[TBL] [Abstract][Full Text] [Related]
3. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.
Sarwal MM; Yorgin PD; Alexander S; Millan MT; Belson A; Belanger N; Granucci L; Major C; Costaglio C; Sanchez J; Orlandi P; Salvatierra O
Transplantation; 2001 Jul; 72(1):13-21. PubMed ID: 11468528
[TBL] [Abstract][Full Text] [Related]
4. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
Sarwal MM; Vidhun JR; Alexander SR; Satterwhite T; Millan M; Salvatierra O
Transplantation; 2003 Nov; 76(9):1331-9. PubMed ID: 14627912
[TBL] [Abstract][Full Text] [Related]
5. [Early steroid withdrawal in pediatric renal transplantation].
Delucchi B A; Valenzuela A M; Ferrario B M; Lillo D AM; Guerrero G JL; Rodríguez S E; Cano Sch F; Cavada Ch G; Godoy L J; Rodríguez H J; González G G; Buckel B E; Contreras M L
Rev Med Chil; 2006 Nov; 134(11):1393-401. PubMed ID: 17277852
[TBL] [Abstract][Full Text] [Related]
6. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.
Nematalla AH; Bakr MA; Gheith OA; Elagroudy AE; Elshahawy el-M; Aghoneim M
Exp Clin Transplant; 2007 Dec; 5(2):673-9. PubMed ID: 18194120
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of steroid-avoidance protocols in pediatric kidney transplant recipients.
Nehus E; Goebel J; Abraham E
Am J Transplant; 2012 Dec; 12(12):3441-8. PubMed ID: 22994143
[TBL] [Abstract][Full Text] [Related]
8. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
Nehus EJ; Liu C; Lu B; Macaluso M; Kim MO
Nephrol Dial Transplant; 2017 Aug; 32(8):1424-1431. PubMed ID: 28810723
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
Stratta RJ; Alloway RR; Hodge E; Lo A;
Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
[TBL] [Abstract][Full Text] [Related]
10. Can pediatric steroid-free renal transplantation improve growth and metabolic complications?
Bhakta N; Marik J; Malekzadeh M; Gjertson D; Ettenger R
Pediatr Transplant; 2008 Dec; 12(8):854-61. PubMed ID: 18482211
[TBL] [Abstract][Full Text] [Related]
11. Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants.
Ellis D
Pediatr Nephrol; 2000 Jul; 14(7):689-94. PubMed ID: 10912544
[TBL] [Abstract][Full Text] [Related]
12. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study.
Grenda R; Watson A; Trompeter R; Tönshoff B; Jaray J; Fitzpatrick M; Murer L; Vondrak K; Maxwell H; Van Damme-Lombaerts R; Loirat C; Mor E; Cochat P; Milford DV; Brown M; Webb NJA
Am J Transplant; 2010 Apr; 10(4):828-836. PubMed ID: 20420639
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
[TBL] [Abstract][Full Text] [Related]
16. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
Ciancio G; Burke GW; Suzart K; Roth D; Kupin W; Rosen A; Olson L; Esquenazi V; Miller J
Transplantation; 2002 Apr; 73(7):1100-6. PubMed ID: 11965039
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center.
Michael M; Minard CG; Kale AS; Brewer ED
Pediatr Transplant; 2016 Feb; 20(1):49-58. PubMed ID: 26916966
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis.
Ciancio G; Gaynor JJ; Zarak A; Sageshima J; Guerra G; Roth D; Brown R; Kupin W; Chen L; Tueros L; Hanson L; Ruiz P; Burke GW
Transplantation; 2011 Jun; 91(11):1198-205. PubMed ID: 21107305
[TBL] [Abstract][Full Text] [Related]
19. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.
Gheith OA; Nematalla AH; Bakr MA; Refaie A; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2011 Apr; 9(2):121-7. PubMed ID: 21453230
[TBL] [Abstract][Full Text] [Related]
20. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.
Li L; Chang A; Naesens M; Kambham N; Waskerwitz J; Martin J; Wong C; Alexander S; Grimm P; Concepcion W; Salvatierra O; Sarwal MM
Am J Transplant; 2009 Jun; 9(6):1362-72. PubMed ID: 19459814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
